RBC Capital analyst Trung Huynh initiates coverage on AstraZeneca (AZN:LN) (NASDAQ: AZN) with a Outperform rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Intl Ratings New Coverage